Study of Ukrainian price market of medicines for scalp seborrheic dermatitis treatment
DOI:
https://doi.org/10.14739/2409-2932.2018.3.145254Keywords:
pharmaceutical preparations, marketing, dermatologic agents, pharmaceutical feesAbstract
Considering mostly long time use of medicines by the patients with scalp seborrheic dermatitis (SSD) the social-economical availability of medications with antiseborrheic activity becomes important and the price of medicine appear as a certain measure.
The aim of this work is the study of price characteristics of medicines for SSD treatment on the domestic pharmaceutical wholesale market and also the analysis of their availability for the Ukrainian South region consumers.
Materials and methods. In this work the logical, statistical, monitoring methods were used. Price-lists of famous wholesale firms at Ukrainian pharmaceutical market and also retail prices of medications with antiseborrheic action were analyzed.
Results. The analysis of pharmaceutical price market of antiseborrheic medications, which are of the greatest use among population, was carried out. Calculated liquidity ratio for the most antiseborrheic medications has value about 0.5. Indexes of adequate paying capacity factor indicate availability of such home-made remedies as Ketokonazol Fytopharm (0.31), Ketodin 90.96), Ketozoral-Darnitsa (1.00), Dermazol 91.16) and dermazol Plus (1.17). Sulsena paste 1 % (0.17), Sulsena forte paste 2 % (0.19), shampoo “Zelenaya apteka” (0.40), Sulsena shampoo (0.88) are the most available medications for South region in “medical cosmetics” segment. The tar shampoo “911” – (RF) – 0.50, tar shampoo– (RF) – 0.51 and tar shampoo “Aptechka Agafyi” – (RF) – 0.92 are the most available from imported shampoos.
Conclusion. On basis of carried out calculations it was determined that the high price competition is typical for all medications of described segment of medications with the exception of Kenazol, Ketokonazol-Fitopharm, Nizoral, Ebersept, Keto Plus, Skin-Cap. Calculated adequate paying capacity factors and factors of availability show the low availability of many antiseborrheic medications for consumers and this fact determines necessity of creating new domestic remedies with antiseborrheic action on the purpose of increasing level of providing the population with effective and available remedies.
References
Mikhnova, I. N. (2012). E'tapnoe lechenie seborejnogo dermatita volosistoj chasti golovy [Treatment of seborrheic dermatitis of the hairy part of the head]. Dermatologiya i venerologiya, 2, 44–47. [in Russian].
Kalinina, O. V., Evstafyev, V. V., & Albanova, V. I. (2014). Terapiya seborejnogo dermatita volosistoj chasti golovy [Therapy of seborrheic dermatitis of the head]. Rossijskji zhurnal kozhnykh i venericheskikh boleznej, 2, 48–53. [in Russian].
Olisova, O. Yu., & Davidovich, M. I. (2014). Sovremennyi podkhod k lecheniyu seborejnogo dermatita [A modern approach to therapy of seborrheic dermatitis]. Rossijskji zhurnal kozhnykh i venericheskikh boleznej, 4, 31–35. [in Russian].
Hromovyk, B. P., Hasiuk, H. D., & Levytska, O. R. (2004). Farmatsevtychnyi marketynh: teoretychni ta prykladni zasady [Pharmaceutical marketing: theoretical and applied principles]. Vinnytsia: Nova Knyha. [in Ukrainian].
Nemchenko, A. S., & Kosiachenko, K. L., & Nemchenko, O. A. (2012) Tsinoutvorennia na likarski zasoby [Pricing is on medications]. Kharkiv: Apostrof [in Ukrainian].
McDonald, M., & Wilson, H. (2011) Marketing plans: how to prepare them, how to use them. Chichester: «Wiley».
Solodovnik, V. A., Tkachenko, N. O., Gladysheva, S. А., & Al Zedan, Fadi (2018). Doslidzhennia rynku zasobiv dlia likuvannia seboreinoho dermatytu volosystoi chastyny holovy [Study of medicines’ market for the treatment of seborrheic dermatitis of the pilar part of head]. Current issues in pharmacy and medicine: science and practice, 1(26), 112–118. [in Ukrainian]. doi: 10.14739/2409-2932.2018.1.123730.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)